Competitive Position

Competitive Position

FinVolution is a strong operator in a business with weak barriers. Set against six listed Chinese loan-facilitation peers, it is the second most profitable of the group, but its take rate, credit performance and funding are middle-of-the-pack — nothing structural separates it from rivals in its China core, where the largest peer, Qifu, earns 2.4 times its profit at a comparable loss rate. Its one durable, hard-to-copy advantage sits offshore: a multi-year overseas head start no peer has matched. On the evidence, a narrow moat.

The peer set

All six comparables run a recognisably similar model: a Cayman-listed platform that matches Chinese consumer borrowers to licensed institutional funders (banks, consumer-finance companies, trusts), takes a fee, and carries some of the credit risk through a guarantee. That shared structure is why the group is a fair mirror — and why size, not model, is what separates them.

*Lufax figures FY2025; it ran a net loss, so ROE is not meaningful and its take rate is not comparable (it is a small-business-owner and secured lender, larger-ticket than FINV's consumer micro-loans). **Lexin figures are FY2024 (its latest 20-F); all others FY2025. ROE = net income ÷ year-end shareholders' equity. Sources: FINV FY2025 20-F [1], [2], [3]; QFIN FY2025 20-F [4], [5], [6]; Lufax FY2025 20-F [7]; Lexin FY2024 20-F [8], [9], [10]; X Financial FY2025 20-F [11], [12], [13]; Jiayin FY2025 20-F [14], [15], [16]; Yiren FY2025 20-F [17], [18], [19].

Qifu is the scale leader by a distance: RMB327.1 billion of loan volume against FinVolution's RMB200.3 billion, and RMB5.99 billion of net income — 2.4 times FinVolution's RMB2.54 billion [20][21]. Below Qifu, FinVolution is the most profitable name in the group: its RMB2.54 billion tops Jiayin (RMB1.54 billion), X Financial (RMB1.46 billion), Lexin (RMB1.10 billion) and Yiren (RMB0.05 billion), and stands against a RMB1.70 billion loss at the larger Lufax [22][23][24]. That places FinVolution as a solid second — profitable, mid-scale, but not the operator others must react to.

Net income attributable to shareholders; latest fiscal year (FY2025 except Lexin FY2024). Sources as in the table above: FINV [25]; QFIN [26]; JFIN [27]; XYF [28]; LX [29]; YRD [30]; LU [31].

No structural edge in China

A moat should show up in numbers — in pricing, in credit, or in a funding cost rivals cannot match. On each of those tests FinVolution reads as competent rather than advantaged.

Pricing. Expressed as net revenue over loan volume — a rough take rate — the comparable consumer lenders cluster in a narrow band. FinVolution's 6.8% sits at the top of that band, but only just above Lexin's 6.7% and within a point of Qifu's and X Financial's 5.9%.

Derived from each company's reported net revenue and loan volume (latest fiscal year; Lexin FY2024). †Yiren's figure is flattered by non-lending revenue — roughly an eighth of its total comes from insurance brokerage and lifestyle services rather than loan facilitation. Lufax excluded (different, larger-ticket model). Sources: net-revenue and volume citations as in the peer table — FINV [32][33]; QFIN [34][35]; LX [36][37]; XYF [38][39]; JFIN [40][41]; YRD [42][43].

The narrow spread is what commoditised pricing looks like: rates are set less by any platform's brand than by the regulatory ceiling all of them face and the returns institutional funders demand. A clean loan-facilitation take rate near 7% is respectable, not a source of advantage.

Credit. On the closest like-for-like measure — the point-in-time 90-day-plus delinquency rate on the outstanding book — FinVolution again sits in the middle. Its China book ran at 2.85% at end-2025, just above Qifu's 2.71% and below Lufax's 3.4% and Lexin's 3.6% [44][45][46][47]. The remaining three report on bases that do not line up cleanly — Jiayin discloses a vintage-based M3+ rate rather than a book delinquency rate [48], and X Financial's disclosed buckets deteriorated sharply, its 91-to-180-day delinquency rate climbing to 6.31% at end-2025 from 2.48% a year earlier [49]. The read across the group is that credit is cyclically softening for everyone; FinVolution is managing it as well as the best and better than the weakest, but its underwriting is not visibly a class apart.

Funding. Every platform draws on the same pool of licensed lenders, on non-exclusive terms. FinVolution had cumulatively worked with 115 institutional funding partners in China as of end-2025 [50]; the same banks, consumer-finance companies and trusts fund its rivals, and no single partner is committed to any one platform. That is a shared, contestable input, not a proprietary one — which is why the whole group also carries credit risk on the loans it places, FinVolution included, rather than earning a pure risk-free fee [51].

The China lending economics are examined in Guarantee Economics; the point here is comparative. Nothing in pricing, credit or funding gives FinVolution an edge a well-run rival lacks. In its home market it is a good operator in a crowded, rate-capped business — which is closer to execution than to a moat.

The overseas head start

FinVolution's clearest separation from the peer set is offshore. It has built a scaled international business while the rest of the group has barely started.

FinVolution FY2025: international loan origination RMB14.0 billion (up from RMB7.9 billion in 2023), 24.6% of revenue, 5.9 million overseas unique borrowers, funded through 18 overseas institutional partners. Source: FY2025 20-F [52]; overseas revenue share per Overseas Engine.

Against that, the peer field is thin. Qifu began overseas expansion only in 2024, extending into "several overseas markets" with no overseas scale disclosed [53]. Jiayin opened an Indonesia office back in 2019 but has since disposed of its Nigeria operations and shows little overseas volume [54]. Yiren is the earliest of the followers into FinVolution's own markets, but frames the Philippines and Indonesia as businesses to "gradually expand" from a small base [55]. Lexin and X Financial were China-only in their latest filings.

Sources: FINV FY2025 20-F [56]; YRD Q4 FY2025 transcript [57]; QFIN FY2025 20-F [58]; JFIN FY2025 20-F [59]; LX FY2024 20-F [60]; XYF FY2025 20-F [61]; LU FY2025 20-F [62].

This lead is harder to copy than a China take rate. It rests on things that take years to assemble in each market: local lending licences, a repeat-borrower base (87.6% of overseas volume in 2025 came from returning borrowers), and underwriting data on populations with little formal credit history [63]. A peer entering Indonesia today starts where FinVolution stood several years and 18 funding relationships ago.

A narrow moat

The evidence points to a narrow moat. FinVolution has no structural advantage in its China core — it prices, underwrites and funds much like its rivals, and a larger peer out-earns it while reserving as conservatively. What it does have is a scaled, hard-to-replicate overseas franchise that every competitor is years behind on, and a second-place profit standing that says it executes well.

The strongest fact against calling even that a moat is size and quality of earnings. The overseas franchise, for all its lead, is still under a quarter of revenue and earns a mid-single-digit operating margin against China's high-twenties, so the durable edge is real but does not yet carry the group's profitability — the detail is in Overseas Engine. A first-mover position that does not yet earn first-mover economics is a narrow moat, not a wide one.

What would change the read in either direction is observable. What would widen the read is overseas operating margins converging toward China's as the borrower base seasons, which would turn a revenue lead into a profit moat. What would narrow it is Yiren, Qifu or a fresh entrant reaching real scale in Indonesia or the Philippines within a few years, which would show the head start was a timing advantage rather than a barrier. Both are checkable in the segment disclosures from here.